"China esophageal cancer radiation therapy guide" interpretation tour media conference held a grand

Winter is all over the night, the year is open and tomorrow is long.
January 16, 2021 by the Chinese Physicians Association Of Radiation Oncology Physicians Branch, the Chinese Medical Association Radiation Oncology Treatment Credit Association, the China Anti-Cancer Association Of Cancer Radiation Therapy Professional Committee co-sponsored by the "generation, new life" - "China esophageal cancer radiation therapy guide 2020 edition" interpretation of the media conference held online.
the world's top radiotherapy experts gathered in the cloud to witness the release of the new guide with more than 26,000 online viewers.
the conference was attended by academician Yu Jinming of Shandong Cancer Hospital and Professor Li Baosheng of Shandong Cancer Hospital as President of the General Assembly.
In his opening remarks, Professor Li Baosheng thanked Academician Yu Jinming for his strong support and guidance in the formulation and revision of the Guide, so that the Guide can embody the principles of norms, characteristics and practicality - both covering the relevant norms of comprehensive treatment and highlighting the clinical issues of concern in the diagnosis and treatment of esophageal cancer: such as target area drawing, dose optimization, quality control, etc.
he recalled the positive feedback he had received from his peers following the release of the first edition of the Guide, as well as the constructive comments made by his colleagues.
also prompted the editorial board to further revise the Guidelines and to publish a new version of the guidelines at the annual meeting of the Radiotherapy Branch of the Chinese Physicians Association in November 2020.
Li Baosheng looks forward to further promoting the standardized diagnosis and treatment of tumors and promoting the progress of the industry through the development of guidelines and a series of lecture activities.
speech, the Special Guest of the Chinese Academy of Sciences, Mr. Yu Jinming, fully affirmed the hard work and fruitful results of the editorial board of all the guides led by Professor Li Baosheng.
the history of more than a century, radiotherapy has become an indispensable and important means in the process of tumor treatment.
esophageal cancer is one of the most common tumors in the world, on the one hand, the morbidity and mortality rate of esophageal cancer in China are high, and its causes, epidemiology and many aspects are many different from among the West.
It is the tireless efforts of Professor Li Baosheng and clinical and basic experts that have enabled us to move from fully referring to Western experience and guidance to being able to have our Guide to China today, and to increasingly make our Voices of China more and more heard internationally. The publication of the new edition of the
Guidelines not only means that China has the most authoritative, scientific and up-to-date reference and guidance in the field of radiotherapy for esophageal cancer, but also means that patients with esophageal cancer will be able to get better and more effective treatment.
After the speech, with the experts present online together to make the launch gesture, glory countdown and together to celebrate the "scratch generation of new" theme of the General Assembly, "China esophageal cancer radiation therapy guide 2020 edition" successfully released.
of the General Assembly, Professor Fu Xiaolong of Shanghai Jiaoxuan University's affiliated chest hospital served as academic chair.
He mentioned that the esophageal cancer radiotherapy guidelines are very practical and important work done by the three universities in their joint efforts, and that the publication and follow-up promotion of the guidelines can effectively help medical workers to update their awareness and enhance their abilities.
Wei, of Shandong Cancer Hospital in China, brought us a wonderful interpretation of the target area sketch in the Guide.
On the one hand, he reviewed the epidemiological characteristics of esophageal cancer in China, expounded the guiding ideology of the expert group norms, characteristics and landing in the process of formulating the Guide, at the same time, he also combed the advantages and disadvantages of different examination methods for the stage of esophageal cancer, emphasizing that the standardization and rational application of various imaging means is the cornerstone of precision radiotherapy of esophageal cancer.
Professor Huang Wei, in conjunction with the guide, elaborated on the considerations in the planning process of the target area, and showed us many details and experiences that need attention in the sketching process, such as the normal structure that is easy to mistake, and carefully combed the lymphatic anatomy around esophageal cancer and its application in the sketching.
Niu Zuxing of Shandong Cancer Hospital in Shandong Province interpreted the drug treatment part of the Guide.
as an expert in digestive medicine, he emphasizes the recommendation of comprehensive treatment principles based on multidisciplinary teams based on a full assessment of patients and tumors.
pointed out that the biological properties of esophageal squamous cancer, despite the bottleneck stage of cytotoxic drug therapy alone, are irreplaceable in synchronous chemotherapy.
At present, the drug treatment of esophageal cancer has entered the era of immunity, Professor Niu Zuxing carefully combed the evidence-based medical evidence of domestic and foreign immunotherapy drugs, including Karelli pearl monotherapy, in the advanced stage of esophageal cancer, second-line and postoperative aids, and looked forward to the addition of immunotherapy on the basis of the current simultaneous chemotherapy can further improve the efficacy.
Jianhua, Center for Cancer Prevention and Control, Sun Yat-sen University, explained the new complementary treatment part of the Guide.
the corresponding evidence-based medical evidence, he pointed out that preoperative chemotherapy is still the current esophageal cancer, especially squamous cancer, the most well-documented treatment model.
And with the widespread use of immunotherapy, its combination with chemotherapy may bring new treatment patterns to esophageal cancer treatment, which still need to be further confirmed by more clinical studies, including the participation of immunotherapy drugs in China.
in the media question session, the experts on the scene for the medical tribune, Sina medicine, tumor lookout, CCMTV clinical channels and other media reporters raised hot issues.
in response to a question about "the future direction and trends of esophageal cancer radiotherapy", Academician Yu Jinming noted that in the recently reviewed revolutionary medical study, from the earliest discovery of X-rays in Lenchen in 1895 to the most recent immunotherapy in 2010, it is very important for the treatment of esophageal cancer.
radiotherapy combined immunotherapy is more institutionally able to play an anti-tumor advantage.
especially with the inclusion of domestic immunological drugs such as carelli-pearl monoigene into health insurance, its combined use with radiotherapy will certainly play an increasingly important role in the clinical research and treatment of esophageal cancer.
Li Baosheng spoke again in the interview about the original intention of developing the Guide and the update of the new edition.
On the one hand, because of the characteristics of esophageal cancer in China, but also taking into account the current domestic and foreign esophageal cancer guidelines are comprehensive, the lack of radiotherapy, an important treatment for esophageal cancer specialized guidelines, so experts to regulate, characteristics, landing as the guiding ideology of the development of radiotherapy guidelines.
the guidelines in conjunction with feedback from the promotion process and the latest clinical evidence.
Huang Wei further introduced the new version of the guide for new auxiliary cycles, target area sketching, dose limits and other updates.
of the hot issues are also focused on immunotherapy.
interview, Professor Niu Zuoxing further reviewed the evolution of immunotherapy from basic research to clinical transformation and achieved encouraging results.
In particular, China's independent research and development of immunological drugs, including Karelli pearl monoanti, etc. through a series of clinical studies in ESCORT so that immunotherapy from the back line gradually to the front line, first-line or even auxiliary, new auxiliary treatment, has made great progress.
Professor Fu Xiaolong also believes that, combined with the mechanisms of immunotherapy and the accumulated clinical evidence, the forward trend of immunotherapy in the treatment of esophageal cancer is inevitable.
, Professor Wang Ping further shared with you the latest findings of his team's 2020 ASTRO conference, which reached 80 per cent PFS and 85 per cent OS in one year, with very encouraging results.
Fu Jianhua further shared the use of immunological drugs and clinical focus in the new complementary treatment.
his concluding remarks to the General Assembly, Professor Li Baosheng once again thanked each participant in the development and revision of the Guide for their hard work.
2020 is a long time coming, and 2021 has arrived, which is to be expected.
As Said by academician Yu Jinming, "China Esophageal Cancer Radiotherapy Guide 2020 Edition" interpretation of the tour media release of the esophageal cancer curry from the actual clinical problems, multi-dimensional explanation of esophageal cancer radiation therapy, comprehensive treatment, together to lead everyone to enjoy the most cutting-edge academic feast.
People's health is an important part of the country's soft power, I believe that through the continuous efforts of each radiotherapist, under the guidance of the Guide to better treatment for the benefit of the vast number of esophageal cancer patients, we will be able to further implement the healthy China 2030 planning outline, to build a healthy China.
"China esophageal cancer radiation therapy guide" interpretation tour media release playback long press identification QR code